![](/img/cover-not-exists.png)
Transient ischaemic attack after spacing the dose of alirocumab: Is it advisable to reduce the doses of PCSK9 inhibitors with very low LDL-cholesterols?
Piqueras Ruiz, Sandra, Parra Virto, Alejandro, Torres do Rego, Ana, Demelo RodrÃguez, Pablo, Ãlvarez-Sala Walther, LuisVolume:
32
Journal:
ClÃnica e Investigación en Arteriosclerosis (English Edition)
DOI:
10.1016/j.artere.2019.04.002
Date:
January, 2020
File:
PDF, 387 KB
2020